Adaptive Biotechnologies Corporation - SIC # -

Ticker Exchange SIC # Website Latest Ticker
ADPT Nasdaq www.adaptivebiotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adaptive Biotechnologies Corporation

Adaptive Biotechnologies (ADPT) After Loss Forecasts Improve Is The Rally Already Priced In - Jul 24th, 2026 6:11 am
Adaptive Biotechnologies (ADPT) Stock May Be 22% Undervalued As Growth Hopes Build - Jul 24th, 2026 2:10 am
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Jul 23rd, 2026 8:00 am
Will Earnings Estimate Upgrades and a Smaller Projected Loss Change Adaptive Biotechnologies' (ADPT) Narrative? - Jul 22nd, 2026 11:11 pm
Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Jul 22nd, 2026 8:00 am
Adaptive Biotechnologies (ADPT) Upgraded to Buy: What Does It Mean for the Stock? - Jul 21st, 2026 10:00 am
Are Medical Stocks Lagging DexCom (DXCM) This Year? - Jul 21st, 2026 7:40 am
An Adaptive Biotechnologies Insider Sold $8.5 Million in Stock After an 85% Run - Jul 12th, 2026 3:58 pm
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 - Jul 9th, 2026 2:05 pm
Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial - Jun 30th, 2026 6:30 am
Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) - Jun 29th, 2026 11:30 am
BTIG Maintains a Buy Rating on Adaptive Biotechnologies (ADPT) - Jun 27th, 2026 4:13 pm
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering - Jun 17th, 2026 4:00 am
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses - Jun 15th, 2026 2:10 pm
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering - Jun 15th, 2026 2:05 pm
What Does an Adaptive Biotech Insider's Sale of Nearly 40,000 Shares Mean for Investors? - Jun 14th, 2026 4:46 pm
Adaptive Biotechnologies (ADPT) Moves 9.7% Higher: Will This Strength Last? - Jun 12th, 2026 3:44 am
OpenFold Consortium Adds Eleven New Members as Momentum Builds for Open AI Infrastructure in Biology and Drug Discovery - Jun 9th, 2026 7:00 am
How The Adaptive Biotechnologies (ADPT) Narrative Is Shifting Around A US$20 Fair Value Anchor - Jun 4th, 2026 5:10 am
Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference - Jun 3rd, 2026 4:04 pm